TITLE

Graft Acceptance and Rejection

AUTHOR(S)
Platt, Jeffrey L.
PUB. DATE
January 2001
SOURCE
Encyclopedic Reference of Cancer;2001, p372
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
This entry provides the definition of the term "Graft Acceptance and Rejection." The term refers to the fate of cells, tissues or organs transplanted between different individuals. The process depends upon the nature of the graft and on the genetic differences between the donor and the recipient. Transplanted cells, such as bone marrow cells or hepatocytes, derive their vascular supply, nutrition and growth factors mainly from the graft recipient.
ACCESSION #
23678044

 

Related Articles

  • Hyperacute Rejection.  // Encyclopedic Reference of Cancer;2001, p437 

    A definition of the term "hyperacute rejection" is presented. The term refers to the destruction of engrafted organs that commonly happens within 24 hours of transplantation. Hyperacute rejection is caused by preformed antibodies and activation of complement donor cells.

  • 11: Kidney-Transplant Patients Survive With-out Drugs. Bakalar, Nicholas // Discover;Jan2009, Vol. 30 Issue 1, p32 

    The article, one in a series of the top science stories of 2008, focuses on a procedure for organ transplantation begun at Massachusetts General Hospital in Boston that eliminates the need for long-term drugs. Patients with end-stage renal disease who were given kidney transplants along with...

  • Humoral rejection of human organ transplants. Michaels, Paul J.; Fishbein, Michael C.; Colvin, Robert B. // Springer Seminars in Immunopathology;Sep2003, Vol. 25 Issue 2, p119 

    Although T-cell mediated rejection has remained the most common form of acute rejection, humoral rejection now accounts for a substantial fraction in patients with kidney or heart allografts, and probably causes the majority of acute graft losses. The frequency, variously estimated at 20-30%, is...

  • A complementary approach to treating antibody-mediated transplant rejection. Heeger, Peter S. // Kidney International;Jul2010, Vol. 78 Issue 2, p125 

    Current treatment for antibody-mediated kidney transplant rejection is inadequate. Tillou and colleagues administered recombinant C1 inhibitor to block complement activation to prevent antibody-initiated injury in sensitized baboon recipients of kidney allografts. These early but encouraging...

  • mycophenolate mofetil. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p526 

    A definition of the term "mycophenolate mofetil," which refers to an immunosuppresant drug used following organ transplanted to reduce the risk of the body rejecting the organ, is presented.

  • ARTERIO--VENOUS SHUNTING IN RENAL TRANSPLANT REJECTION. Zimmerman, Robert; Sprayregen, Seymour // Angiology;Jan1978, Vol. 29 Issue 1, p40 

    Arterio-venous (A-V) shunting has been reported with renal transplant rejection in one previous case. Two additional cases with this finding are presented. The pathophysiologic basis of A-V shunting and its possible prognostic significance are discussed.

  • A Non-Invasive Approach to Detecting Organ Rejection by MRI: Monitoring the Accumulation of Immune Cells At the Transplanted Organ. Ho, Chien; Hitchens, T. K. // Current Pharmaceutical Biotechnology;Dec2004, Vol. 5 Issue 6, p551 

    Organ transplantation is the generally preferred medical procedure of treatment for patients with end-stage organ failure. The immunological reaction of rejection is a major cause of functional failure in transplant patients. The current �gold standard� for detecting or confirming...

  • DRhigh+CD45RA--Tregs Potentially Affect the Suppressive Activity of the Total Treg Pool in Renal Transplant Patients. Schaier, Matthias; Seissler, Nicole; Schmitt, Edgar; Meuer, Stefan; Hug, Friederike; Zeier, Martin; Steinborn, Andrea // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Recent studies show that regulatory T cells (Tregs) play an essential role in tolerance induction after organ transplantation. In order to examine whether there are differences in the composition of the total CD4+CD127low+/-FoxP3+-Treg cell pool between stable transplant patients and patients...

  • Differentiation between chronic rejection and chronic cyclosporine toxicity by analysis of renal cortical mRNA. Koop, Klaas; Bakker, Rene C.; Eikmans, Michael; Baelde, Hans J.; de Heer, Emile; Paul, Leendert C.; Bruijn, Jan A. // Kidney International;Nov2004, Vol. 66 Issue 5, p2038 

    Differentiation between chronic rejection and chronic cyclosporine toxicity by analysis of renal cortical mRNA.Background.In kidney transplantation, chronic allograft nephropathy (CAN) is the major cause of graft loss. Causes of CAN include chronic rejection and chronic cyclosporine A (CsA)...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics